0R15 8539.0 2.1534% 0R1E 8600.0 3.3654% 0M69 None None% 0R2V 190.25 -0.1312% 0QYR 1345.5 2.0871% 0QYP 424.0 0.5931% 0LCV 146.6464 -1.3147% 0RUK None None% 0RYA 1631.0 -0.6094% 0RIH 171.3 0.9131% 0RIH 174.9 2.1016% 0R1O 186.0 9820.0% 0R1O None None% 0QFP None None% 0M2Z 298.3 -0.6495% 0VSO None None% 0R1I None None% 0QZI 474.5 0.6363% 0QZ0 220.0 0.0% 0NZF None None%

BSF Enterprise Plc

Healthcare GB BSFA

4.75GBP
-(-%)

Last update at 2024-05-16T14:34:00Z

Day Range

4.624.74
LowHigh

52 Week Range

6.6523.88
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -0.92943M -0.05833M -0.09384M -
Minority interest - - - -
Net income -0.93004M -0.05843M -0.09393M -
Selling general administrative 0.66M 0.09M 0.09M -
Selling and marketing expenses 0.00559M - - -
Gross profit -0.16051M - - -
Reconciled depreciation 0.02M - - -
Ebit -0.92732M -0.05843M -0.09393M -0.02520M
Ebitda -0.90580M -0.05822M -0.09376M -
Depreciation and amortization 0.02M 0.00021M 0.00017M -
Non operating income net other - - - -
Operating income -0.92732M -0.05822M -0.09376M -
Other operating expenses 0.93M 0.06M 0.09M 0.05M
Interest expense 0.00211M 0.00011M 0.00009M 0.00000M
Tax provision 0.00061M 0.00000M 0.00000M -
Interest income - - - -
Net interest income -0.00215M -0.00011M -0.00009M -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.00061M 0.00011M 0.00009M -
Total revenue 0.00000M 0.00000M 0.00000M -
Total operating expenses 0.77M 0.06M 0.09M -
Cost of revenue 0.16M - - -
Total other income expense net -0.00211M -0.00011M -0.00009M -
Discontinued operations - - - -
Net income from continuing ops -0.93004M -0.05833M -0.09384M -
Net income applicable to common shares -0.93004M -0.05833M -0.09384M -0.08714M
Preferred stock and other adjustments - - - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 4.03M 0.40M 0.46M 0.55M
Intangible assets - - - -
Earning assets - - - -
Other current assets 0.17M 0.04M 0.01M -
Total liab 0.45M 0.04M 0.03M 0.04M
Total stockholder equity 3.58M 0.36M 0.42M 0.52M
Deferred long term liab - - - -
Other current liab 0.17M 0.02M 0.03M 0.03M
Common stock 0.86M 0.20M 0.20M 0.20M
Capital stock 0.86M 0.20M 0.20M 0.20M
Retained earnings -1.00102M -0.24657M -0.18824M -0.09440M
Other liab 0.01M - - -
Good will - - - -
Other assets - - - -
Cash 1.06M 0.36M 0.45M 0.55M
Cash and equivalents - - - -
Total current liabilities 0.30M 0.04M 0.03M 0.04M
Current deferred revenue - - - -
Net debt -0.82965M -0.35987M -0.44506M -0.55220M
Short term debt 0.07M - - -
Short long term debt - - - -
Short long term debt total 0.23M - - -
Other stockholder equity 3.72M 0.41M 0.41M 0.41M
Property plant equipment 0.30M - - -
Total current assets 1.25M 0.40M 0.46M 0.55M
Long term investments - - - -
Net tangible assets 1.10M 0.36M 0.42M 0.52M
Short term investments - - - -
Net receivables 0.15M 0.03M - -
Long term debt - - - -
Inventory 0.02M - - -
Accounts payable 0.06M 0.01M 0.00496M 0.00792M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total 2.78M 0.00000M 0.00000M 0.00000M
Capital lease obligations 0.23M - - -
Long term debt total - - - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments 0.00175M - - -
Change to liabilities 0.13M 0.00437M -0.00296M 0.03M
Total cashflows from investing activities 0.00175M 0.00175M 0.00175M 0.00175M
Net borrowings -0.01403M -0.01403M -0.01403M -0.01403M
Total cash from financing activities 1.37M 1.37M 1.37M 0.56M
Change to operating activities -0.10000M -0.10000M -0.10000M -0.10000M
Net income -0.92943M -0.05833M -0.09384M -0.08714M
Change in cash 0.70M -0.08519M -0.10714M 0.51M
Begin period cash flow 0.36M 0.45M 0.55M -
End period cash flow 1.06M 0.36M 0.45M 0.55M
Total cash from operating activities -0.66724M -0.08519M -0.10714M -0.05463M
Issuance of capital stock 1.75M - 0.00000M -
Depreciation 0.02M 0.02M 0.02M 0.02M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables 0.03M -0.03124M -0.01034M -0.01034M
Sale purchase of stock -0.36882M - - -
Other cashflows from financing activities -0.01403M -0.36882M -0.36882M -0.18980M
Change to netincome 0.18M 0.18M 0.18M 0.18M
Capital expenditures 0.01M 0.01M 0.01M 0.01M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 0.07M -0.02687M -0.01330M -
Stock based compensation - - - -
Other non cash items 0.18M - - -
Free cash flow -0.67786M -0.08519M -0.10714M -

Fundamentals

  • Previous Close 4.75
  • Market Cap10.33M
  • Volume158473
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.74427M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.02919M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
BSFA
BSF Enterprise Plc
- -% 4.75 - - - 1.92 -8.8768
ONT
Oxford Nanopore Technologies Ltd
-2.0 1.76% 111.50 - - 10.88 2.75 8.77 -16.7946
GNS
Genus PLC
-14.0 0.74% 1880.00 42.59 25.71 2.08 2.46 2.31 16.39
PRTC
PureTech Health plc
-0.5 0.22% 222.00 - - 35.55 1.04 95.87 -4.5333
AVCT
Avacta Group PLC
-0.75 1.69% 43.50 - - 23.19 14.78 20.75 -10.4566

Reports Covered

Stock Research & News

Profile

BSF Enterprise Plc does not have significant operations. It intends to acquire the businesses within biotechnology, innovative marketing, and e-commerce sectors. The company was incorporated in 2018 and is based in London, United Kingdom.

BSF Enterprise Plc

201 Bishopsgate, London, United Kingdom, EC2M 3AB

Key Executives

Name Title Year Born
Mr. Geoffrey Robert Baker B.Com., LL.B., MBA Company Sec. & Non-Exec. Director 1956

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions